Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65580 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C36H50N6O5Color and Shape:Off-White SolidMolecular weight:646.38427Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C14H14O3Color and Shape:PowderMolecular weight:230.09429Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H21N3O5Color and Shape:White Off-White SolidMolecular weight:395.14812Atazanavir S,R,S,S-diastereomer ((3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:White Off-White SolidMolecular weight:704.38975Apixaban
CAS:Lactams, nesoiFormula:C25H25N5O4Color and Shape:Off-White White SolidMolecular weight:459.19065Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H15ClN2O2Color and Shape:White Off-White CrystalsMolecular weight:206.08221Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C8H8N2OSColor and Shape:White Off-White PowderMolecular weight:180.03573Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18FNO2SColor and Shape:Off-White PowderMolecular weight:331.10423Bupropion Hydrochloride Related Compound B (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18BrNO·HClColor and Shape:Off-White PowderMolecular weight:319.03385Fluconazole Related Compound C (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C10H8N6Color and Shape:White PowderMolecular weight:212.08104Naproxen Related Compound L (1-(6-methoxynaphthalen-2-yl)ethanone)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C13H12O2Color and Shape:White Crystalline PowderMolecular weight:200.08373Copovidone
CAS:Vinyl copolymers in primary forms, nesoiFormula:(C6H9NO)n(C4H6O2)mColor and Shape:White Yellow PowderMolecular weight:197.23 g/molO-Desmethyl Apremilast ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C21H22N2O7SColor and Shape:Pale Yellow SolidMolecular weight:446.11477Silodosin S-Enantiomer
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C25H32F3N3O4Color and Shape:White Off-White Crystalline PowderMolecular weight:495.23449Naproxen Sodium
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C14H13NaO3Color and Shape:White Cream PowderMolecular weight:252.07624Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:Off-White CrystalsMolecular weight:315.16569Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Ezetimibe
CAS:Lactams, nesoiFormula:C24H21F2NO3Color and Shape:White PowderMolecular weight:409.14895Nadolol Related Compound B ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C14H20O5Color and Shape:White SolidMolecular weight:268.13107Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFormula:C13H9NOColor and Shape:Yellow Green SolidMolecular weight:195.068411,3-Bis(isopropylamino)propan-2-ol Dihydrochloride (1,3-bis(isopropylamino)propan-2-ol Dihydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C9H24Cl2N2OColor and Shape:White Off-White PowderMolecular weight:246.12657Dealkyl Atazanavir (Methyl [(5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C26H43N5O7Color and Shape:White PowderMolecular weight:537.31625Benzyl Alcohol
CAS:Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formula:C7H8OColor and Shape:Colorless Clear LiquidMolecular weight:108.14 g/molLeflunomide Related Compound C (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H9F3N2O2Color and Shape:Yellow White PowderMolecular weight:270.06161Rivaroxaban Ethylamino Analog (1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H20ClN3O4S·2HClColor and Shape:White Off-White SolidMolecular weight:409.0863Fluvoxamine Maleate
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C15H21F3N2O2·C4H4O4Color and Shape:White Off-White Crystalline PowderMolecular weight:318.15551Oxcarbazepine Related Compound A (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H12N2O3Color and Shape:Pale Yellow PowderMolecular weight:280.08479Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H12N2O2Color and Shape:White PowderMolecular weight:216.08988Sorafenib Related Compound H (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H16ClF3N4O3Color and Shape:Pale Yellow SolidMolecular weight:464.0863Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C36H36N6O10Color and Shape:Off-White SolidMolecular weight:712.24929Aripiprazole Spiro Analog (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H19Cl2N2·BrColor and Shape:White Off-White SolidMolecular weight:285.09253Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFormula:C7H6F3NColor and Shape:White Light Yellow LiquidMolecular weight:161.04523Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H17N3O2Color and Shape:White Off-White PowderMolecular weight:187.13208Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C25H24Cl2N4O6S2Color and Shape:White Off-White SolidMolecular weight:610.05143Mirabegron Racemate
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White PowderMolecular weight:396.162Aleuritic Acid
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormula:C16H32O5Color and Shape:PowderMolecular weight:304.22497Clioquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5ClINOColor and Shape:PowderMolecular weight:304.91044R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS:Lactams not elsewhere specified or includedFormula:C24H21F2NO3Color and Shape:White Off-White SolidMolecular weight:409.148954-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C17H21N·HClColor and Shape:White Off-White SolidMolecular weight:239.1674Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H13NOColor and Shape:White Off-White PowderMolecular weight:211.09971Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4·HClColor and Shape:Off-White SolidMolecular weight:327.09858Nadolol
CAS:Aromatic drugs of amino-alcohols, other than those contFormula:C17H27NO4Color and Shape:White PowderMolecular weight:309.4 g/molAnhydrous Lactose (A Mixture of α and β anomers)
CAS:Lactose and lactose syrup, containing by weight 99% or more lactose, expressed as anhydrous lactose, calculated on the dry matterFormula:C12H22O11Color and Shape:White Off-White PowderMolecular weight:342.11621Sucralose
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C12H19Cl3O8Color and Shape:White Off-White Crystalline PowderMolecular weight:396.01455N-Carbamoyl Oxcarbazepine (N-Carbamoyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H13N3O3Color and Shape:White SolidMolecular weight:295.09569S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H16N2O3Color and Shape:White Off-White SolidMolecular weight:188.11609Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C40H42N4O6Color and Shape:Off-White Light Brown SolidMolecular weight:674.31044Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H13N3O2SColor and Shape:Dark Brown PowderMolecular weight:311.07285Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormula:C17H23N3OColor and Shape:Off-White PowderMolecular weight:285.18411Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:Pale Yellow SolidMolecular weight:704.87Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194Bupropion Amine Tosylate (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C16H18ClNO4SColor and Shape:White SolidMolecular weight:355.06451Ambrisentan Related Compound B (2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C16H16O4Color and Shape:Off-White PowderMolecular weight:272.10486Metoprolol Related Compound A ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C14H23NO3Color and Shape:White Clumpy PowderMolecular weight:253.16779Bendroflumethiazide
CAS:Sulfonamides used as drugsFormula:C15H14F3N3O4S2Color and Shape:PowderMolecular weight:421.42Carvedilol Related Compound A (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C36H43N3O7Color and Shape:PowderMolecular weight:629.3101Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4Color and Shape:Off-White PowderMolecular weight:329.13756Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H19NO·HClColor and Shape:White PowderMolecular weight:241.12334Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H17ClO3Color and Shape:Pale Yellow Clear LiquidMolecular weight:244.08662Ambrisentan Related Compound C (2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-hydroxy-3,3-diphenylpropanoic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H20N2O4Color and Shape:White Off-White SolidMolecular weight:364.14231Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H21Cl2N3O7S2Color and Shape:Off-White SolidMolecular weight:597.0198Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS:Lactams, nesoiFormula:C8H14N2O2Color and Shape:White Off-White PowderMolecular weight:170.10553Regorafenib Related Compound A (4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C13H12FN3O2Color and Shape:Brown Violet PowderMolecular weight:261.09135Rivaroxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H18ClN3O5SColor and Shape:White PowderMolecular weight:435.065572-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H9NOColor and Shape:Brown LiquidMolecular weight:123.06841Sunitinib N-Oxide ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide)
CAS:Lactams, nesoiFormula:C22H27FN4O3Color and Shape:Yellow Orange SolidMolecular weight:414.20672Monoiodoamiodarone ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H30INO3Color and Shape:Colorless Semi-SolidMolecular weight:519.12704Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFormula:C19H27N3O6S2Color and Shape:Off-White PowderMolecular weight:457.13413Alectinib Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C30H34N4O2·HClMolecular weight:482.26818Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormula:C7H16O3SColor and Shape:Clear Yellow LiquidMolecular weight:180.08202O-Desmethylmetoprolol (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C14H23NO3Color and Shape:White Off-White SolidMolecular weight:253.16779Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H22FNO3Color and Shape:Light Tan PowderMolecular weight:343.15837Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C20H18N2OColor and Shape:Off-White Fine PowderMolecular weight:302.141913-Acetamidophthalic acid (3-acetamidophthalic acid)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H9NO5Color and Shape:Off-White SolidMolecular weight:223.04807Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C17H17N3OColor and Shape:White PowderMolecular weight:279.137164-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,4-dichlorophenyl)propan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H17Cl2NO·HClColor and Shape:Off-White PowderMolecular weight:273.06872Deoxybicalutamide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfonyl)-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O3SColor and Shape:SolidMolecular weight:414.06613Apremilast
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C22H24N2O7SMolecular weight:460.13042Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C23H25Cl2N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:445.13238Apremilast Open Ring 3-acetamide ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C22H26N2O8SColor and Shape:Off-White SolidMolecular weight:478.14099Desiodoamiodarone ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H31NO3Color and Shape:Colorless LiquidMolecular weight:393.23039Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C13H16N2O4Color and Shape:White Off-White SolidMolecular weight:264.11101Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSHClColor and Shape:White Off-White PowderMolecular weight:315.16569Ranitidine Hydrochloride
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormula:C13H22N4O3S·HClColor and Shape:White Pale Yellow PowderMolecular weight:350.11794Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C19H23NO4·HClColor and Shape:Off-White SolidMolecular weight:365.13939Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18ClNO·HClColor and Shape:White PowderMolecular weight:275.08437Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C39H39N3O6Color and Shape:Off-White PowderMolecular weight:645.28389Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H2Cl2O2SColor and Shape:White Off-White SolidMolecular weight:195.91526Fluticasone Propionate
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C25H31F3O5SColor and Shape:White PowderMolecular weight:500.18443Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C11H11F2N3O2Color and Shape:White SolidMolecular weight:255.08193Aripiprazole Hydroxydihydroquinolinone Analog (7-hydroxy-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C9H9NO2Color and Shape:White Off-White SolidMolecular weight:163.063335-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H6O3Color and Shape:Yellow SolidMolecular weight:126.03169Norepinephrine Bitartrate
CAS:Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormula:C8H11NO3·C4H6O6·H2OColor and Shape:White Light Grey Crystalline PowderMolecular weight:337.1009Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C19H23F3N2O5Color and Shape:Off-White SolidMolecular weight:416.15591Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H23NO4SColor and Shape:White Crystalline PowderMolecular weight:397.13478Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C21H26F2O5Color and Shape:White Light Yellow Crystalline SolidMolecular weight:396.17483Bicalutamide Related Compound B ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O4SColor and Shape:White Pale Pink PowderMolecular weight:430.37Ezetimibe System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderAtazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O7·H2SO4Color and Shape:Off-White SolidMolecular weight:690.3741
![Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478593.webp&w=3840&q=75)
![Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1229883.webp&w=3840&q=75)